A new report reveals the heavy personal and economic toll of MS and recommends more complete, patient focused approaches to ...

Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in ...

Multiple sclerosis (MS) is a chronic condition that affects the central nervous system. MS is considered to be an immune-mediated disease, which is a disease that causes the body’s immune system to ...

Oligodendrocytes may show early immune-like changes in multiple sclerosis (MS), according to findings from a mouse study.

Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...

Experts in MS discuss the challenges related to treatment selection and management when MS disease progression occurs. Neil Minkoff, MD: There’s a group of patients that, no matter what we start, will ...

Multiple sclerosis (MS) and Lyme disease are diseases that stem from very different causes. MS is a life-long autoimmune condition that disrupts the communication between your brain and your body.

Treatment with fenebrutinib in a 2-year open-label extension study led to significantly reduced disease-related inflammatory activity in those with relapsing MS, according to speaker at ECTRIMS ...

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study suggests that supplementing it in high doses could help reduce symptoms. The ...

A virus that infects more than 90% of adults and causes the “kissing disease” has been linked with the onset of multiple sclerosis in a new study. Researchers at Harvard University have added further ...

Infectious mononucleosis – also known as "mono" or "the kissing disease" – in childhood or adolescence is associated with an increased risk of developing multiple sclerosis (MS) as an adult, according ...